In The News

Profiles: What you need to know about the latest NC IDEA grant winners

Read original article at WRAL Techwire.

DURHAM – Who are the companies that comprise the spring 2018 cohort of NC IDEA SEED grant program? Here’s a look at each.

REDEFINING ASTHMA CARE

VitalFlo Inc.—Raleigh, NC—$50,000

Luke Marshall, founder and CEO of VitalFlo with mobile spirometer. Copyright VitalFlo Inc.

VitalFlo is redefining the standard of care for asthma management by providing actionable recommendations to patients when they need it most: before they have an asthma attack.

“VitalFlo’s vision is to build a future without asthma attacks,” said Luke Marshall, founder and CEO of VitalFlo. “Our lung health analytics platform, powered by its handheld medical device and digital health management app, enables asthmatic patients to track their lung health and asthma medications at home.”

There are 25 million Americans that suffer from asthma symptoms, said Marshall. “That’s 25 million Americans that aren’t sure about whether they’ll have trouble breathing today, whether they’ll miss school or work today, or about whether they’ll be one of the 10 Americans that will die today from asthma.”

The company’s VitalFlo mobile spirometer and smartphone application enables anyone with asthma symptoms or medications monitor their lung function. They company uses predictive analytics to determine whether a patient is at risk of an attack, and notifies them so they can avoid missed days, trips to the emergency room, or worse.

The VitalFlo mobile spirometer was invented by the company’s CTO, James Dieffenderfer, who recently completed a biomedical engineering doctorate degree at North Carolina State University. The company’s COO, Ravi Chilukuri, brings more than 20 years of experience in leading development teams, most notably serving as the vice president of product development at Phononic.

“It’s been a privilege to work with this great team,” said Marshall, “as we work to build VitalFlo into a company with enough scale to really make an impact for asthmatics everywhere.”